You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 2, February 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Surgery, Other
 •Alert me on articles by topic

Ultrasound Can Estimate the Pathologic Size of Infiltrating Ductal Carcinoma

Christina A. Finlayson, MD; Tracey A. MacDermott, BA

Arch Surg. 2000;135:158-159.

Hypothesis  Ultrasound (US) of the breast will accurately measure breast tumor size when compared with size as determined by pathologic examination.

Design  Retrospective case series.

Setting  University hospital–based breast center.

Patients  Thirty-five women with a diagnosis of breast cancer who had US as a component of their evaluation.

Main Outcome Measure  Tumor size as measured by US compared with size measured by pathologic examination.

Results  Size measured by US ranged from 0.45 to 3.81 cm. Size measured by pathologic examination ranged from 0.5 to 5 cm. The mean difference of size measured by US vs pathologic size was 0.4 cm (P = .01). When only tumors with invasive ductal histology are evaluated, the mean difference in size is 0.33 cm (P = .008). The range of difference was -1.6 cm to +0.42 cm. Seventeen percent of invasive ductal tumors were underestimated by more than 1 cm; none were underestimated by more than 2 cm.

Conclusions  This study demonstrates that, although US tends to underestimate the pathologic tumor size, 83% of invasive ductal tumors fall within a 1-cm and 100% fall within a 2-cm extension of the US-measured tumor size. Therefore, it is possible to use US to monitor the extent of treatment size when developing very localized therapeutic tools.


From the Department of Surgery, University of Colorado Health Sciences Center, Denver.


RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(2):241-242.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intraoperative ultrasound localization of nonpalpable breast cancers.
Ngo et al.
Ann. Surg. Oncol. 2007;14:2485-2489.
ABSTRACT | FULL TEXT  

Small Invasive Breast Carcinomas in Taiwanese Women
Chao et al.
Ann. Surg. Oncol. 2003;10:740-747.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.